Patents by Inventor Fahim Atif

Fahim Atif has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CANCERS AND COMPOSITIONS RELATED THERETO
    Publication number: 20140296195
    Abstract: Use of compounds disclosed herein, typically progesterone or analog or derivative thereof, in the treatment of central nervous system cancers, specifically neuroblastoma and glioblastoma is provided. The treatment offers a reduced toxicity as compared to the currently available chemotherapeutic agents. The progesterone may be administered alone or in combination with, or in conjunction with other therapeutic agents.
    Type: Application
    Filed: June 11, 2014
    Publication date: October 2, 2014
    Inventors: Donald G. Stein, Iqbal Sayeed, Fahim Atif
  • Method for the treatment of central nervous system cancers and compositions related thereto
    Patent number: 8778915
    Abstract: Use of compounds disclosed herein, typically progesterone or analog or derivative thereof, in the treatment of central nervous system cancers, specifically neuroblastoma and glioblastoma is provided. The treatment offers a reduced toxicity as compared to the currently available chemotherapeutic agents. The progesterone may be administered alone or in combination with, or in conjunction with other therapeutic agents.
    Type: Grant
    Filed: March 4, 2013
    Date of Patent: July 15, 2014
    Assignee: Emory University
    Inventors: Donald G. Stein, Iqbal Sayeed, Fahim Atif
  • METHOD FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CANCERS AND COMPOSITIONS RELATED THERETO
    Publication number: 20130310350
    Abstract: Use of compounds disclosed herein, typically progesterone or analog or derivative thereof, in the treatment of central nervous system cancers, specifically neuroblastoma and glioblastoma is provided. The treatment offers a reduced toxicity as compared to the currently available chemotherapeutic agents. The progesterone may be administered alone or in combination with, or in conjunction with other therapeutic agents.
    Type: Application
    Filed: March 4, 2013
    Publication date: November 21, 2013
    Applicant: EMORY UNIVERSITY
    Inventors: Donald G. Stein, Iqbal Sayeed, Fahim Atif
  • Method for the treatment of central nervous system cancers and compositions related thereto
    Patent number: 8435972
    Abstract: Use of compounds disclosed herein, typically progesterone or analog or derivative thereof, in the treatment of central nervous system cancers, specifically neuroblastoma and glioblastoma is provided. The treatment offers a reduced toxicity as compared to the currently available chemotherapeutic agents. The progesterone may be administered alone or in combination with, or in conjunction with other therapeutic agents.
    Type: Grant
    Filed: August 31, 2011
    Date of Patent: May 7, 2013
    Assignee: Emory University
    Inventors: Donald G. Stein, Iqbal Sayeed, Fahim Atif
  • METHOD FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM CANCERS AND COMPOSITIONS RELATED THERETO
    Publication number: 20120058978
    Abstract: Use of compounds disclosed herein, typically progesterone or analog or derivative thereof, in the treatment of central nervous system cancers, specifically neuroblastoma and glioblastoma is provided. The treatment offers a reduced toxicity as compared to the currently available chemotherapeutic agents. The progesterone may be administered alone or in combination with, or in conjunction with other therapeutic agents.
    Type: Application
    Filed: August 31, 2011
    Publication date: March 8, 2012
    Applicant: EMORY UNIVERSITY
    Inventors: Donald G. Stein, Iqbal Sayeed, Fahim Atif